Logo image of AVNT.CA

AVANT BRANDS INC (AVNT.CA) Stock Fundamental Analysis

TSX:AVNT - Toronto Stock Exchange - CA05353D2023 - Common Stock - Currency: CAD

1.35  -0.07 (-4.93%)

Fundamental Rating

3

Overall AVNT gets a fundamental rating of 3 out of 10. We evaluated AVNT against 34 industry peers in the Pharmaceuticals industry. While AVNT seems to be doing ok healthwise, there are quite some concerns on its profitability. AVNT does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

Quickly go to:

2

1. Profitability

1.1 Basic Checks

AVNT had negative earnings in the past year.
AVNT had a positive operating cash flow in the past year.
AVNT had negative earnings in each of the past 5 years.
AVNT had negative operating cash flow in 4 of the past 5 years.
AVNT.CA Yearly Net Income VS EBIT VS OCF VS FCFAVNT.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2017 2018 2019 2020 2021 2022 2023 0 5M -5M -10M -15M

1.2 Ratios

AVNT has a worse Return On Assets (-20.67%) than 63.64% of its industry peers.
The Return On Equity of AVNT (-32.54%) is comparable to the rest of the industry.
Looking at the Return On Invested Capital, with a value of 0.10%, AVNT is in the better half of the industry, outperforming 66.67% of the companies in the same industry.
Industry RankSector Rank
ROA -20.67%
ROE -32.54%
ROIC 0.1%
ROA(3y)-13.2%
ROA(5y)-17.22%
ROE(3y)-16.97%
ROE(5y)-22.71%
ROIC(3y)N/A
ROIC(5y)N/A
AVNT.CA Yearly ROA, ROE, ROICAVNT.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2017 2018 2019 2020 2021 2022 2023 0 -100 -200 -300 -400 -500

1.3 Margins

With a decent Operating Margin value of 0.29%, AVNT is doing good in the industry, outperforming 66.67% of the companies in the same industry.
With a Gross Margin value of 45.15%, AVNT perfoms like the industry average, outperforming 57.58% of the companies in the same industry.
AVNT's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 0.29%
PM (TTM) N/A
GM 45.15%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-11.77%
GM growth 5YN/A
AVNT.CA Yearly Profit, Operating, Gross MarginsAVNT.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2017 2018 2019 2020 2021 2022 2023 0 -100 -200 -300 -400

More info and screens

4

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so AVNT is destroying value.
AVNT has more shares outstanding than it did 1 year ago.
AVNT has more shares outstanding than it did 5 years ago.
Compared to 1 year ago, AVNT has a worse debt to assets ratio.
AVNT.CA Yearly Shares OutstandingAVNT.CA Yearly Shares OutstandingYearly Shares Outstanding 2017 2018 2019 2020 2021 2022 2023 50M 100M
AVNT.CA Yearly Total Debt VS Total AssetsAVNT.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2017 2018 2019 2020 2021 2022 2023 20M 40M 60M 80M

2.2 Solvency

Based on the Altman-Z score of -0.44, we must say that AVNT is in the distress zone and has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of -0.44, AVNT is in line with its industry, outperforming 54.55% of the companies in the same industry.
AVNT has a debt to FCF ratio of 7.34. This is a slightly negative value and a sign of low solvency as AVNT would need 7.34 years to pay back of all of its debts.
AVNT's Debt to FCF ratio of 7.34 is fine compared to the rest of the industry. AVNT outperforms 72.73% of its industry peers.
A Debt/Equity ratio of 0.23 indicates that AVNT is not too dependend on debt financing.
With a Debt to Equity ratio value of 0.23, AVNT perfoms like the industry average, outperforming 57.58% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.23
Debt/FCF 7.34
Altman-Z -0.44
ROIC/WACC0.01
WACC8.05%
AVNT.CA Yearly LT Debt VS Equity VS FCFAVNT.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2017 2018 2019 2020 2021 2022 2023 0 20M 40M

2.3 Liquidity

A Current Ratio of 2.13 indicates that AVNT has no problem at all paying its short term obligations.
AVNT's Current ratio of 2.13 is fine compared to the rest of the industry. AVNT outperforms 63.64% of its industry peers.
A Quick Ratio of 1.06 indicates that AVNT should not have too much problems paying its short term obligations.
AVNT's Quick ratio of 1.06 is in line compared to the rest of the industry. AVNT outperforms 45.45% of its industry peers.
Industry RankSector Rank
Current Ratio 2.13
Quick Ratio 1.06
AVNT.CA Yearly Current Assets VS Current LiabilitesAVNT.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2017 2018 2019 2020 2021 2022 2023 10M 20M 30M

More info and screens

3

3. Growth

3.1 Past

AVNT shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -6768.52%.
The Revenue has been growing slightly by 0.82% in the past year.
The Revenue has been growing by 49.36% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)-6768.52%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-8011.52%
Revenue 1Y (TTM)0.82%
Revenue growth 3Y49.36%
Revenue growth 5YN/A
Sales Q2Q%30.41%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
AVNT.CA Yearly Revenue VS EstimatesAVNT.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2017 2018 2019 2020 2021 2022 2023 5M 10M 15M 20M 25M
AVNT.CA Yearly EPS VS EstimatesAVNT.CA Yearly EPS VS EstimatesYearly EPS VS Estimates 2017 2018 2019 2020 2021 2022 2023

More info and screens

2

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for AVNT. In the last year negative earnings were reported.
Industry RankSector Rank
PE N/A
Fwd PE N/A
AVNT.CA Price Earnings VS Forward Price EarningsAVNT.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

AVNT's Enterprise Value to EBITDA ratio is rather cheap when compared to the industry. AVNT is cheaper than 93.94% of the companies in the same industry.
Based on the Price/Free Cash Flow ratio, AVNT is valued cheaper than 84.85% of the companies in the same industry.
Industry RankSector Rank
P/FCF 6.52
EV/EBITDA 5.65
AVNT.CA Per share dataAVNT.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 -1 2 3 4

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

AVNT does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

AVANT BRANDS INC

TSX:AVNT (2/21/2025, 7:00:00 PM)

1.35

-0.07 (-4.93%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryPharmaceuticals
Earnings (Last)10-14 2024-10-14
Earnings (Next)02-26 2025-02-26
Inst OwnersN/A
Inst Owner ChangeN/A
Ins Owners8.14%
Ins Owner ChangeN/A
Market Cap14.51M
Analysts0
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.49
P/FCF 6.52
P/OCF 4.99
P/B 0.31
P/tB 0.38
EV/EBITDA 5.65
EPS(TTM)-1.6
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)0.21
FCFY15.33%
OCF(TTM)0.27
OCFY20.05%
SpS2.76
BVpS4.29
TBVpS3.59
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -20.67%
ROE -32.54%
ROCE 0.15%
ROIC 0.1%
ROICexc 0.11%
ROICexgc 0.13%
OM 0.29%
PM (TTM) N/A
GM 45.15%
FCFM 7.5%
ROA(3y)-13.2%
ROA(5y)-17.22%
ROE(3y)-16.97%
ROE(5y)-22.71%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-11.77%
GM growth 5YN/A
F-Score5
Asset Turnover0.41
Health
Industry RankSector Rank
Debt/Equity 0.23
Debt/FCF 7.34
Debt/EBITDA 2.19
Cap/Depr 14.23%
Cap/Sales 2.31%
Interest Coverage 250
Cash Conversion 59.39%
Profit Quality N/A
Current Ratio 2.13
Quick Ratio 1.06
Altman-Z -0.44
F-Score5
WACC8.05%
ROIC/WACC0.01
Cap/Depr(3y)42.22%
Cap/Depr(5y)175.8%
Cap/Sales(3y)8.97%
Cap/Sales(5y)65.97%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-6768.52%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-8011.52%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)0.82%
Revenue growth 3Y49.36%
Revenue growth 5YN/A
Sales Q2Q%30.41%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y103.9%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y134.92%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y157.96%
OCF growth 3YN/A
OCF growth 5YN/A